1699PEfficacy and safety of VEGFR2 inhibitor apatinib combined with chemotherapy for sarcoma in stage IV

ConclusionsChemotherapy combined with apatinib significantly increases the response rate and shows manageable adverse events.Legal entity responsible for the studyThe authors.FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research